Generics 17

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Decitabine manufacturers

17 products found

Filters

17 products found

decitabine

Injection 50 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Serbia , Vietnam
Available for
Licensing with supply, Technology transfer
Manufacturer #12180
It is a pharmaceutical company focused on discovering, licensing, and manufacturing generics and added-value medications that meet stringent quality standards set by the FDA and the EMA. They design and produce in accordance with European quality standards. They have over 30 years of experience and have completed over 30 licensing agreements around the world.

Manufacturer usually replies in 6 days

decitabine

Powder and solvent for solution for injection/infusion 50 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
Canada
GMP approvals
FDA, Canada
Comments
Reference product : Dacogen (Otsuka)
Manufacturer #278

The company has become a prominent partner of the pharmacy community in North America, with the fastest rising market share among generic leaders. It can provide best-in-class supply reliability thanks to production capacity. In more than 50 countries, it's available locally or through corporate partnerships. R&D expenditures range from $40 million to $50 million per year. They are dedicated to maintaining a customer satisfaction rate of over 95% by continuously enhancing supply chain efficiency.

Manufacturer usually replies in 7 days

decitabine

Vials, lyophilized injection 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #1338

Manufacturer usually replies in 7 days

decitabine

Injection, lyophilized 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #15176

Manufacturer usually replies in 4 days

decitabine

Powder and solvent for solution for injection 50 mg - 20 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP, PICS
Manufacturer #2760

Manufacturer usually replies in 5 days

decitabine

Vials, injection 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #9406

Manufacturer usually replies in 7 days

decitabine

Vials, lyophilized injection 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Manufacturer #2722
It originally entered the pharmaceutical industry in 1987, when it introduced blood derivative products to Europe and became the exclusive distributor for prominent European brands. Oncology, hematology, dermatology, radiology, rheumatology, immunology, and OTC products are the seven main therapeutic fields.

Manufacturer usually replies in 6 days

decitabine

Vials, injection 50mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
WHO
Manufacturer #16160

Manufacturer usually replies in 4 days

decitabine

Vials, injection 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
WHO
Manufacturer #15160

Manufacturer usually replies in 5 days

decitabine

Solution for injection 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
WHO
Manufacturer #13096

Manufacturer usually replies in 5 days

decitabine

Powder for solution for injection 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21110

Manufacturer usually replies in 6 days

decitabine

Ampoules, injection 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #16454
A pharmaceutical company based in South America with 15+ years of experience in a drug market. More than 40 products in 25+ countries: LATAM; Wester, Southern and South-eastern Asia. Company’s therapeutic areas consist of products that can used in such areas as: urology, oncology, rare diseases and more.

Manufacturer usually replies in 7 days

decitabine

Injection 50mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
PICS
Registered in
China , Turkey
Available for
Licensing with supply, Distribution only
Manufacturer #18302

Manufacturer usually replies in 27 days

decitabine

Vials, lyophilized injection 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17753

Manufacturer usually replies in 10 days

decitabine

Powder for solution for injection 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #31064

decitabine

Vials, lyophilized injection 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #30013

Manufacturer usually replies in nan days

decitabine

Injection 50 mg

Dossier type
CTD
Dossier status
Outdated
Country of origin
India
GMP approvals
WHO
Manufacturer #31073

Manufacturer usually replies in 10 days

What is the Decitabine drug?

Decitabine is a chemical analog of cytidine, a nucleoside present in DNA and RNA. Decitabine drug is used for the treatment of myelodysplastic syndromes, and for acute myeloid leukemia. As a cancer medicine, Decitabine slows the growth and spread of cancer cells. In the US, the FDA approved the medical use of Decitabine in 2006.

Decitabine manufacturers and wholesalers:

Decitabine's most known brand name is Dacogen by Otsuka Pharmaceuticals Co, Ltd. Some of Decitabine suppliers are Accord Healthcare, Cipla, and Chemi Spa. Decitabine suppliers market it in the form of lyophilized powder for solution for injection of 50 mg/20 ml or 50 mg/10ml.

Decitabine for sales:

In the US, Dacogen powder for injection 50 mg can cost from $324.50 to $1706.4.
On Pipelinepharma pharmaceutical market place, Linagliptin is most available from Turkey, India, Argentina, and China. The online platform helps the distributors to find qualified Linagliptin manufacturers globally, ensuring you they are not fraudulent websites. Using the integrated search engine of the marketplace, you can find a list of many pharmaceutical products for sale, including Linagliptin. Each Linagliptin manufacturer or supplier product description encompasses lots of information about the medication such as form, dose, manufacturing site approvals, and regulatory status. Then using the simple one-click contact form, you can enquire about the supply price if none are listed and place an order or send inquiries to companies no matter where they are in the world. Not only is this marketplace good news for distributors and other buyers, but wholesale sellers and manufacturers benefit as well. They can register and list an unlimited number of pharmaceutical products free of charge.

How to use Decitabine drugs?

There are two ways to be administered Decitabine for treatment. The first one is 15 mg/m2 IV over 3 hours; the patient should repeat every 8 hours for three days and repeat this cycle every six weeks. The second one is 20 mg/m2 IV over 1 hour; the patient should repeat this daily for five days and repeat this cycle every four weeks. Taking Decitabine can cause some side effects, the most common ones include black, tarry stools, bladder pain, bleeding after defecation, bleeding gums, blood in the urine or stools, blue lips and fingernails.